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ABSTRACT The plasmid-located mcr-9 gene, encoding a putative phosphoethano-
lamine transferase, was identiﬁed in a colistin-resistant human fecal Escherichia coli
strain belonging to a very rare phylogroup, the D-ST69-O15:H6 clone. This MCR-9
protein shares 33% to 65% identity with the other plasmid-encoded MCR-type en-
zymes identiﬁed (MCR-1 to -8) that have been found as sources of acquired resis-
tance to polymyxins in Enterobacteriaceae. Analysis of the lipopolysaccharide of the
MCR-9-producing isolate revealed a function similar to that of MCR-1 by adding a
phosphoethanolamine group to lipid A and subsequently modifying the structure of
the lipopolysaccharide. However, a minor impact on susceptibility to polymyxins was
noticed once the mcr-9 gene was cloned and produced in an E. coli K-12-derived
strain. Nevertheless, we showed here that subinhibitory concentrations of colistin in-
duced the expression of the mcr-9 gene, leading to increased MIC levels. This induc-
ible expression was mediated by a two-component regulatory system encoded by
the qseC and qseB genes located downstream of mcr-9. Genetic analysis showed that
the mcr-9 gene was carried by an IncHI2 plasmid. In silico analysis revealed that the
plasmid-encoded MCR-9 shared signiﬁcant amino acid identity (ca. 80%) with the
chromosomally encoded MCR-like proteins from Buttiauxella spp. In particular, Butt-
iauxella gaviniae was found to harbor a gene encoding MCR-BG, sharing 84% iden-
tity with MCR-9. That gene was neither expressed nor inducible in its original host,
which was fully susceptible to polymyxins. This work showed that mcr genes may
circulate silently and remain undetected unless induced by colistin.
KEYWORDS Escherichia coli, MCR, MCR-9, colistin, plasmid, polymyxin
Acquired resistance to polymyxins in Enterobacteriaceae may arise from two mainpathways, namely, chromosomally encoded resistance mechanisms corresponding
to mutations or deletions in genes involved in the biosynthesis of the lipopolysaccha-
ride (LPS) or the acquisition of plasmid-mediated mcr genes. The latter genes encode
phosphoethanolamine transferases that modify the lipid A moiety of the LPS, subse-
quently leading to resistance to polymyxins (1, 2). There have been eight different
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groups ofmcr genes identiﬁed, with some variants described within some given groups
(3–11). mcr-1 likely originates from a Moraxella species (12), while Moraxella plurani-
malium is the exact progenitor of mcr-2 (13), Aeromonas spp. that of mcr-3-like genes
(14, 15), and Shewanella spp. that of mcr-4-like genes (7). The origins of the more
recently discovered mcr genes (mcr-5 to -8) remain unknown. In addition, a very recent
study identiﬁed the mcr-9 gene from a colistin-susceptible Salmonella enterica serotype
Typhimurium isolate recovered from a U.S. patient in 2010 (16).
The high prevalence of MCR (particularly MCR-1)-producing Escherichia coli isolates
in food-producing animals, and therefore the high rate of colistin-resistant isolates, may
be explained by the signiﬁcant use of colistin in veterinary medicine, in particular in
livestock for the treatment of poultry, swine, and cattle (17–20). In humans, the
prevalence of MCR producers seems to be more limited, with many studies reporting
a low prevalence of themcr-1 gene in Enterobacteriaceae (1, 21). On the other hand, the
prevalence of the mcr-2 to -9 genes remains unknown overall, even though the few
reports are mainly on animal isolates.
In a recent prospective study performed in six different French university hospitals,
despite the fact that the prevalence of fecal colistin-resistant E. coli carried by inpatients
was found to be unexpectedly high (12.7%), the rate of MCR-1 producers was low (4.6%
of the colistin-resistant isolates), and no other known MCR-like enzyme was identiﬁed
(22). Two-thirds of the resistant isolates had mutations in the PmrA/PmrB chromo-
somally encoded two-component systems that are the likely sources of the resistance
phenotype (22). Among those colistin-resistant E. coli isolates that remained negative
for all knownmcr-like genes (mcr-1 tomcr-8) and that did not harbor obvious mutations
in chromosomal genes that might be responsible for acquired resistance, E. coli 68A,
showing a colistin MIC of 8 g/ml, was retained for further characterization.
RESULTS
Identiﬁcation of the mcr-9 gene. Whole-genome sequencing (WGS) of the E. coli
isolate 68A (GenBank assembly accession no. GCA_900500325.1) was used in an
attempt to identify the mechanism leading to this reduced susceptibility to colistin, and
a gene showing signiﬁcant identity to mcr-like genes was identiﬁed. It corresponded to
the newly reportedmcr-9 gene (16) encoding the MCR-9 enzyme, sharing 65% and 63%
amino acid identity with the most closely related MCR-3 and MCR-7 enzymes, respec-
tively, and between 33% and 45% with the other MCR-like enzymes (Fig. 1) (GenBank
accession number MK070339). Phylogenetic analysis performed with MCR-9 and all
FIG 1 Phylogenetic tree obtained for the MCR-type phosphoethanolamine transferases identiﬁed by the distance
method using the Neighbor-Joining algorithm (SeaView software, version 4 [44]). Branch lengths are drawn to scale
and are proportional to the number of amino acid substitutions with 500 bootstrap replications. The distance along
the vertical axis has no signiﬁcance. The percentage of amino acid identity compared to the MCR-9 enzyme is
indicated. The tree was rooted with the MCR-3.1 enzyme. The scale along the horizontal axis is indicated.
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other MCR-type enzymes revealed that MCR-9 was distantly related to all those
enzymes and constituted a distinct cluster.
Isolate 68A showed resistance only to penicillins (with susceptibility to penicillin--
lactamase inhibitors) and tetracycline due to the presence of blaTEM-1 and tet(A) genes.
Multilocus sequence typing analysis showed that isolate 68A belonged to the phylo-
group D-ST69 and was of the O15:H6 serotype. It possessed numerous extraintestinal
virulence genes either on the chromosome (fyuA, irp2, and ompT) or on a pS88-like
IncFIB virulence plasmid (iro operon, iss, ompT, hlyF, and iuc operon) (23). Thus, this
strain corresponds to an extraintestinal pathogenic E. coli (ExPEC) isolate.
Localization of the mcr-9 gene. Analysis of the whole-genome sequence of E. coli
68A using PlaScope (24) showed that the mcr-9 gene was located on an IncHI2
(pMLST2) incompatibility group plasmid (p68) of 225 kb. This plasmid did not carry any
other putative resistance gene. PCR-based replicon typing (PBRT) analysis (25) and
Kieser extraction (26) performed from isolate 68A, followed by gel electrophoresis
analysis, conﬁrmed the whole-genome sequencing (WGS) data.
MCR-9 is a phosphoethanolamine transferase conferring reduced susceptibility
to colistin. Mass spectrometry analysis of the lipid A moiety of the LPS of the
MCR-9-producing E. coli isolate 68A recovered from a colistin-supplemented agar plate
showed an additional peak at m/z 1,920 (Fig. 2). This modiﬁcation corresponded to the
addition of a phosphoethanolamine (PEtN) group to lipid A, as previously reported for
MCR-1 to MCR-3 producers (27–29) (Fig. 2). Surprisingly, no peak at m/z 1,920 was
observed when we performed the same experiment with isolate 68A recovered from a
colistin-free medium (Fig. 2). These results strongly suggested that the isolate 68A did
not produce MCR-9 at a level sufﬁcient to signiﬁcantly modify its LPS under the
colistin-free condition and therefore that the expression of mcr-9 was induced in the
colistin-containing plate.
The mcr-9 gene alone then was cloned into the arabinose-inducible pBAD vector,
leading to E. coli TOP10(pBAD-mcr-9), in which the expression of mcr-9 is high in the
presence of L-arabinose. Mass spectrometry analysis of the lipid A moiety of the LPS of
both MCR-9- and MCR-3.12-producing recombinant E. coli TOP10 pBAD-mcr-9 and
pBAD-mcr-3.12 recombinant strains, both recovered from an L-arabinose-supplemented
FIG 2 Mass spectrometry analysis of lipid A from isolate E. coli 68A after growth on a colistin-free LB plate (A), E. coli 68A after growth on a colistin-supplemented
(2 g/ml) LB plate (B), E. coli TOP10(pBAD-mcr-9) recombinant strain induced by L-arabinose (C), E. coli TOP10(pBAD-mcr-3.12) recombinant strain induced by
L-arabinose (D), and E. coli TOP10(pBAD-mcr-9) (not induced by L-arabinose) (E). The addition of phosphoethanolamine is indicated by an arrow.
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agar plate, showed additional peaks at m/z 1,920 not seen for the E. coli TOP10(pBAD-
mcr-9) strain recovered from an L-arabinose-free plate (Fig. 2).
Apart from colistin induction, and since the mcr-9 gene seemed to be poorly
transcribed in its natural host, we evaluated the level of resistance (or reduced
susceptibility) it might confer by comparing it to that of themcr-1 gene. After induction
with arabinose, E. coli TOP10(pBAD-mcr-9) showed a colistin MIC of 0.15 g/ml (sus-
ceptibility range), whereas the same noninduced strain presented a MIC of 0.03 g/ml,
corresponding to a 5-fold increase of the colistin MIC. Conversely, the MIC of colistin for
the E. coli(pBAD-mcr-1) recombinant strain was 4 g/ml. These data conﬁrmed the
impact of the MCR-9 enzyme on colistin susceptibility but to a lower extent than that
of MCR-1.
Genetic context of the mcr-9 gene. Analysis of the genomic data of E. coli 68A
showed that the mcr-9 gene was bracketed by two insertion sequences (IS). Upstream
of mcr-9, IS15DII (IS5 family) was identiﬁed, in which no obvious promoter sequences
that might be responsible formcr-9 expression could be identiﬁed (Fig. 3). Downstream
of mcr-9, another IS, namely, IS903B (IS6 family), was identiﬁed (Fig. 3). No target site
duplication was identiﬁed at the extremities of each IS or when looking at the left-hand
extremity of IS903B and the right-hand extremity of IS903B. The latter observation and
the fact that those two IS are distantly related (with totally different inverted repeat
sequences) likely rule out the hypothesis that mcr-9 was acquired through a composite
transposon bracketed by those two IS.
Analysis of the DNA fragment bracketed by the two above-mentioned IS showed
that four open reading frames were present downstream of mcr-9, including wbuC,
qseC, qseB, and an ATPase gene (Fig. 3). Interestingly, although wbuC encodes a
putative enzyme of the cupin superfamily of unknown function, the qseC and qseB
genes encode a putative two-component system corresponding to a histidine kinase
sensor (QseC) and its cognate partner (QseB). Similar proteins have been shown to play
a role in the signaling network inducing resistance to colistin (30). In order to evaluate
whether those two genes located downstream ofmcr-9 play a role in colistin resistance,
the whole structure encompassing the mcr-9, qseC, and qseB genes along with the two
IS903B and IS15DII elements was cloned, leading to the E. coli TOP10(pBAD-Tot) strain.
The MIC of colistin for this recombinant strain was compared with that of the isogenic
recombinant E. coli TOP10(pBAD-mcr-9), and only a slight increase was observed for E.
coli TOP10(pBAD-Tot) (0.3 versus 0.15 g/ml).
FIG 3 Different genetic structure surrounding the mcr-9 gene. The wbuC, qseC, qseB, and ATPase-encoding genes
located downstream of mcr-9 are represented, as well as the different insertion sequences (IS) bracketing that DNA
fragment, namely, IS903B, IS1R, IS26-like, and IS15DII. Arrows indicate the sense of transcription of those different
genes. (A) Structure surrounding the mcr-9 gene in E. coli isolate 68A (present study) and those identiﬁed in silico
in Leclercia species (GenBank accession no. CP031102.1), Enterobacter hormaechei (CP031575.1), Salmonella enterica
(CP029037.1 and CP006057.1), and Enterobacter kobei (CP032893.1). (B) Structure surrounding the mcr-9 gene
identiﬁed in silico in Leclercia adecarboxylata (MH909331.1) and Salmonella enterica (CP026661.1). (C) Structure
surrounding the mcr-9 gene identiﬁed in silico in Enterobacter cloacae (CP020529.1), Salmonella enterica
(MK191844.1), Cronobacter sakazakii (CP028975.1), and Enterobacter hormaechei (CP031575.1).
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Inducibility ofmcr-9 gene expression. In order to evaluate whether the expression
of mcr-9 was constitutive or inducible in its original host, induction assays were
performed using isolate 68A as the template for mRNA extraction. It is noteworthy that
a 3-fold increase of the mcr-9 mRNA amount was detected once the culture was
induced with 4 g/ml colistin, and a 24-fold increase was detected when using a
concentration of 8 g/ml (Fig. 4). In parallel, the transcription levels of the chromo-
somal pmrA and pmrB genes of E. coli 68A, encoding a response regulator and a sensor
kinase, respectively, which may be involved in acquired resistance to colistin, remained
almost unchanged upon induction (Fig. 4). Also, the amount of transcripts for the
IncHI2 plasmid replicase gene remained unchanged, ruling out the possibility that
induction assays have led to an increased plasmid copy number, thereby biasing the
measurement of the mcr-9 transcription level (data not shown). Of note, no induction
of mcr-9 expression was observed when performing the induction assay with
ampicillin (50 g/ml), suggesting that the colistin inducer effect was quite speciﬁc.
In parallel, the same experiment with colistin (4 g/ml) as the inducer was con-
ducted with E. coli isolate Af23 harboring the mcr-1 gene (31) and exhibiting a
colistin MIC of 4 g/ml, but no induction of mcr-1 was noticed, highlighting the
speciﬁc effect observed in E. coli 68A.
Induction experiments then were performed using recombinant strains E. coli
TOP10(pNK1-mcr-9) (mcr-9 gene alone) and E. coli TOP10(pNK1-Tot) (mcr-9 together
with downstream-located genes wbuC, qseC, and qseB), corresponding to low-copy-
number plasmids not depending on arabinose inducibility. Although no induction of
the mcr-9 expression was observed for E. coli TOP10(pNK1-mcr-9) (data not shown), a
signiﬁcant increase was observed for E. coli TOP10(pNK1-Tot) in the presence of
subinhibitory concentrations of colistin (Fig. 5). Moreover, higher expression levels of
the qseC and qseB genes were concomitantly observed in the presence of colistin (Fig.
5). These data strongly suggest that overexpression of mcr-9 observed in the presence
of colistin is related to that of the QseC-QseB two-component system. Interestingly,
higher expression levels were obtained in the presence of 0.5 g/ml colistin than with
0.06 g/ml colistin, highlighting a concentration-based modulating effect.
Origin of the mcr-9 gene. In silico analysis using the GenBank databases showed
that mcr-9-like genes were present in the chromosomes of Buttiauxella species strains,
including Buttiauxella ferragutiae, Buttiauxella izardii, Buttiauxella noackiae, Buttiauxella
warmboldiae, Buttiauxella brennerae, Buttiauxella agrestis, and Buttiauxella gaviniae. The
most closely related gene, called mcr-BG, was identiﬁed in Buttiauxella gaviniae strain
FIG 4 Expression of ﬁve selected genes in clinical isolate 68A with and without colistin exposure. The
genes are the plasmid-located mcr-9, qseB, and qseC as well as the chromosome-located pmrA (DNA-
binding response regulator) and pmrB (sensor protein) genes. Fold changes in mRNA levels were
determined by RT-qPCR. The data have been normalized to values for reference 16S rRNA genes. Three
independent replicates were performed; the data shown represent the means, and the error bars
represent standard deviations. The asterisks indicate statistical signiﬁcance at different levels by analysis
of variance: *, P 0.1; **, P 0.05; ***, P 0.01; ****, P 0.001; *****, P 0.0001. The different colistin
concentrations used in our assays are shown by color, with blue indicating no colistin, red indicating
4 g/ml colistin, and green indicating 8 g/ml colistin.
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CIP106356T (GenBank accession no. NZ_LXEP00000000.1). The MCR-BG protein shared
84% identity with MCR-9 and 30 to 60% with the other plasmid-encoded MCR-type
enzymes (MCR-1 to -8) (GenBank accession no. WP_064511805.1). Looking at the
sequences located downstream ofmcr-BG, a gene homologous to wbuC was found, but
neither qseC nor qseB homologues were identiﬁed. This suggested that acquisition of
the mcr-9 gene from Buttiauxella spp. occurred together with wbuC as a whole
fragment but that the qseC-qseB tandem originated from another source.
In fact, by performing an in silico BLAST analysis over the GenBank databases with
those two genes, it appeared that they both shared 87% nucleotide identity with
similar genes from Klebsiella aerogenes and Salmonella enterica, respectively. Induction
experiments were performed using B. gaviniae strain CIP106356T with subinhibitory
concentrations of colistin, but no overexpression of mcr-BG was observed (data not
shown).
The mcr-BG gene was cloned in plasmid pBAD and expressed in E. coli TOP10. A
minor impact of the mcr-BG gene on susceptibility to polymyxins was observed once
cloned and produced in E. coli, similar to what was observed with mcr-9 expressed in
E. coli TOP10. After induction with arabinose, an 8-fold increase in the MIC of colistin
was noticed for E. coli TOP10 producing MCR-BG (0.125 g/ml) or producing MCR-9
(0.25 g/ml) compared to that of E. coli TOP10 (0.015 g/ml), while the MIC of colistin
for the MCR-1-producing E. coli TOP10 recombinant strain was 4 g/ml. Analysis of the
LPS pattern of the MCR-BG-producing E. coli conﬁrmed that a PEtN group was added
to the lipid A component of the LPS of E. coli, while no speciﬁc peak was observed when
analyzing the B. gaviniae strain (data not shown).
Distribution of the mcr-9 gene. We performed an in silico analysis using the
GenBank databases to see whether the mcr-9 gene was already present in the available
bacterial genome sequences. Surprisingly, a 100% match at the nucleotide level was
found in ca. 50 genomes, all corresponding to enterobacterial isolates, recovered from
worldwide sources, either from humans or animals (swine). Among the different
enterobacterial species in which mcr-9 was present were Klebsiella spp., Enterobacter
spp., Salmonella spp., Leclercia spp., Citrobacter spp., Raoultella spp., Phytobacter ursingii,
and Cronobacter sakazakii. Information about the colistin susceptibility status of all
these strains unfortunately is not available. Diversity was observed by examining the
genetic environment of themcr-9 gene in all these genomes, with three main structures
identiﬁed (Fig. 3A to C). The IS903B element was always identiﬁed upstream of mcr-9,
and the wbuC gene also was systematically present downstream of it. However,
different IS could be identiﬁed on the right-hand extremity, being either IS15DII, IS1R,
or IS26-like. It is noteworthy that some structures did not encompass the qseC-qseB
regulatory genes.
FIG 5 Expression of three selected genes cloned in E. coli TOP10(pNK1-Tot) with and without colistin
exposure. The genes are mcr-9, qseB, and qseC. Fold changes in mRNA levels were determined by
RT-qPCR. The data have been normalized to values for reference 16S rRNA genes. Three independent
replicates were performed; the data shown represent the means, and the error bars represent standard
deviations. The asterisks indicate statistical signiﬁcance at different levels by ANOVA: *, P 0.05; **,
P 0.01; ***, P 0.001. The different colistin concentrations used in our assays are shown by color, with
blue indicating no colistin, red indicating 0.06 g/ml colistin, and green indicating 0.25 g/ml colistin.
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DISCUSSION
We report here the identiﬁcation of an MCR determinant, detected in a colistin-
resistant E. coli isolate recovered from a patient in France. Interestingly, in contrast to
other MCR determinants identiﬁed so far, MCR-9 confers only reduced susceptibility,
not resistance, to colistin under normal conditions in an E. coli wild-type background.
However, this gene showed increased expression once induced with subinhibitory
colistin concentrations, leading to resistance in E. coli according to EUCAST breakpoints
(www.eucast.org).
The fact that acquisition of mcr-9 does not confer clinical resistance per se suggests
a silent spread of that gene, with elevated MICs of colistin observed for the corre-
sponding producers still categorized as susceptible. It is worth noting that we showed
that the expression of mcr-9 was inducible by subinhibitory concentrations of colistin,
leading to resistance in E. coli. This inducible expression was shown to be related to the
presence of the qseC and qseB genes downstream of mcr-9. Those two genes encode
a putative sensor kinase (QseC) and its cognate partner (QseB), with the former likely
mediating dephosphorylation of the latter (30). This tandem likely has been acquired
through an independent mobilization event with respect to mcr-9 acquisition. This is
suggested by the lack of those genes downstream of the mcr-9-like gene in its original
progenitor, B. gaviniae.
A so-called inducibility of mcr-1 gene expression was recently reported; however,
the phenomenon observed was quite different. In one case, it was shown that themcr-1
gene was truncated by IS1294b, leading to colistin susceptibility in E. coli (32). Upon
colistin-based selective pressure, excision of the IS was observed, leading to restoration
of the intactmcr-1 gene and subsequently to acquired resistance. In the other case, two
copies of a 22-bp DNA insertion were identiﬁed in mcr-1 in Shigella sonnei, leading to
colistin susceptibility (33). Upon loss of one of those two copies, restoration of themcr-1
open reading frame was observed, leading to colistin resistance. Here, we veriﬁed that
the overexpression of mcr-9 was not related to modiﬁcations in the sequences located
in its upstream vicinity (data not shown).
Hence, we speculate that MCR-9 production is a source of colistin resistance upon
selective pressure with that antibiotic, playing a signiﬁcant clinical role in strain
selection. The inducibility property observed withmcr-9 was shown to be related to the
two-component system present downstream of mcr-9. Further work will be conducted
to decipher the exact interactions between those plasmid-borne two-component
regulatory systems and the chromosomally encoded proteins involved in lipopolysac-
charide biosynthesis, particularly those modifying lipid A.
Interestingly, in silico analysis identiﬁed the mcr-9 gene in isolates recovered in 
different parts of the world and in a variety of enterobacterial species. It would be 
interesting to learn about the colistin susceptibility of those mcr-9-positive isolates, 
since that information is not available. Broad epidemiological studies will be necessary 
to evaluate the extent of dissemination of that gene worldwide among human and 
animal isolates. Detection of the mcr-9 gene can be performed by using primers MCR-9F 
(5’-GGT GAA AGT TAT TCC GCT GG-3’) and MCR-9R (5’-TCG CGG TCA GGA TTA 
TAG AC-3’).) and MCR-9R (5=-TCG CGG TCA GGA TTA AC-3=), which were actually 
validated during our study (data not shown). Looking at those genomes available in 
silico, it appeared that different genetic structures sur-rounding the mcr-9 gene could be 
identiﬁed, with some of them lacking the qseC-qseB regulatory genes. We speculate that 
the expression of mcr-9 is not inducible in strains possessing the latter structure.
Isolate 68A belongs to the phylogroup D-ST69 and is of serotype O15:H6. The
phylogroup D-ST69 lineage includes the clonal group A strains ﬁrst described by
Johnson et al. (34) as ExPEC strains responsible for human urinary tract infections and
resistant to trimethoprim-sulfamethoxazole. These strains have a typical virulence
factor proﬁle and exhibit speciﬁc O antigens (O11, O17, O73, and O77) always associ-
ated with the H18 type. However, isolate 68A was susceptible to trimethoprim-
sulfamethoxazole, and the presence of the pS88-like virulence plasmid (35) and of the
7
htt
p:/
/do
c.r
ero
.ch
O15:H6 serotype has not been reported in ST69. A search of ca. 12,000 E. coli genomes
in the NCBI database identiﬁed only 3 genomes corresponding to phylogroup D-ST69-
O15:H6, all being of human origin (one recovered from blood in the United States, one
from an intra-abdominal abscess in China, and one from feces in France), but none of
these strains possessed the mcr-9 gene.
On the other hand, by searching the PLSD plasmid database (36), a total of 26 similar
IncHI2 plasmids were identiﬁed from E. coli, K. pneumoniae, and Salmonella enterica, but
none of them possessed the mcr-9 gene. However, 16 out of those 29 plasmid
sequences contained the mcr-1.1 gene, further suggesting that such a plasmid back-
bone originates from strains present in animal reservoirs subjected to colistin selective
pressure.
Isolate 68A was found to be resistant to colistin in susceptibility testing by broth
microdilution (BMD), as recommended (EUCAST). However, it is noteworthy that the
expression of mcr-9 was actually induced in the presence of colistin when performing
BMD. Therefore, the MIC value actually reﬂects the impact of MCR-9 once the corre-
sponding gene is induced.
Analysis of the LPS proﬁle of isolate 68A as well as MCR-9-producing recombinant
strains showed that the MCR-9 enzyme confers colistin resistance the same way as
MCR-1 and MCR-3 enzymes, by adding a phosphoethanolamine group to the lipid A,
although the different enzymes shared signiﬁcant sequence diversities. The fact that
MCR-1, -2, and -3 share similar functions was previously hypothesized through an in
silico protein structure analysis (5). Here, we showed that MCR-9, along with MCR-BG
and MCR-3, exhibited a very similar three-dimensional structure.
Analysis of the genetic context of the mcr-9 gene did not allow us to explain its
acquisition by the IncHI2 plasmid. The putative involvement of IS903B or IS15DII in the
original mobilization of the mcr-9 gene from Buttiauxella spp. remains elusive. It is
noteworthy that this plasmid did not possess any other antibiotic resistance determi-
nant; therefore, its acquisition through a coselection pressure is unlikely.
MATERIALS AND METHODS
Bacterial isolates and susceptibility testing. The isolates were initially tested for colistin resistance
using agar dilution methods. All colonies growing on plates supplemented with 2 g/ml colistin were
conﬁrmed by the commercialized rapid polymyxin NP test (ELITech Microbiology, France) (37, 38), and
MICs were determined by the BMD method using cation-adjusted Mueller-Hinton (MH) broth (38).
Antimicrobial susceptibility testing for other antibiotic families was performed according to the standard
disk diffusion method on MH agar plates by following CLSI recommendations (39).
WGS and bioinformatic analysis. Whole genomic DNA of isolate 68A was sequenced as previously
described (22) using Illumina NextSeq 2 150-bp technology. The sequences were analyzed with an
in-house bioinformatic pipeline named PETANC, for plasmid exploration typing assembly N= contig
ordering (22), including the PlaScope tool to assess the plasmid origin of the sequence (24).
Plasmid analysis. Plasmid analysis was performed using the Kieser extraction method (26), followed
by gel electrophoresis in order to further conﬁrm the size of the plasmid containing themcr-9 gene using
the E. coli strain 50192 harboring four plasmids of 154, 66, 48, and 7 kb as plasmid size markers. The
determination of the incompatibility group was conﬁrmed by PBRT (27).
Analysis of the LPS modiﬁcation. The LPS of E. coli TOP10 (unmodiﬁed lipid A), of isolate E. coli 68A
(mcr-9 positive) grown in the presence or absence of colistin, of the E. coli(pBAD-mcr-9) clone carrying the
mcr-9 gene in the pBAD vector, grown in the presence or absence of L-arabinose, of B. gaviniae, and of
the E. coli(pBAD-mcr-3.12) clone carrying the mcr-3.12 gene as a control were analyzed by mass
spectrometry (29). Lipid A was extracted using an acetic acid-based procedure as previously described
(40, 41). Once extracted, 0.7 l of the concentrate was spotted on a matrix-assisted laser desorption
ionization–time of ﬂight (MALDI-TOF) plate, followed by addition of 0.7 l of norharmane matrix
(Sigma-Aldrich, St. Louis, Missouri), and then air dried. The samples were analyzed on a Vitek MS
instrument (bioMérieux, Marcy l’Étoile, France) in the negative-ion mode.
Cloning and overexpression of the mcr-9 gene. The mcr-9 gene was cloned into the arabinose-
inducible pBAD vector in order to determine the impact of the expression of the MCR-9 putative
phosphoethanolamine transferase on colistin susceptibility. Primers used for cloning are indicated in
Table 1. Induction of the pBAD vector was performed using MH broth supplemented with 1% L-arabinose
as previously described (42). In addition, to avoid using an arabinose-inducible vector, for the purpose
of colistin inducibility assays, themcr-9 gene and the fullmcr-9 cassette were cloned in low-copy-number
plasmid pNK1 (42) and transformed in E. coli TOP10, giving recombinant plasmids pNK-mcr-9 and
pNK-Tot.
Colistin induction assays. For induction assays with colistin, growth conditions were as follows.
Buttiauxella gaviniae was grown in an LB agar plate, clinical isolate 68A was grown in an LB agar plate
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supplemented with colistin (1 g/ml) or left unsupplemented, and E. coli TOP10 pNK1-mcr-9 and
pNK1-Tot recombinant strains were plated in LB agar supplemented with kanamycin (30 g/ml). All these
strains then were grown overnight in liquid medium before the mRNA extraction assay, with kanamycin
(30 g/ml) being the selective agent of the pNK1 plasmid. A 1/10 dilution culture then was performed
with or without colistin. Induction assays were performed using subinhibitory concentrations of colistin,
namely, 0.12 g/ml for B. gaviniae, E. coli TOP10(pNK1-mcr-9), and E. coli TOP10(pNK1-Tot), 2 g/ml for
clinical isolate 68A, originally recovered onto an LB agar plate without colistin, and 12 g/ml for clinical
isolate 68A, originally recovered from an LB agar plate with colistin. Primers used for cloning are
indicated in Table 1.
mRNA extraction. Cultures of isolate 68A and the recombinant E. coli TOP10 strains harboring
plasmids pNK1-mcr-9 and pNK1-Tot were used for mRNA extraction. They were grown for 3 h. Total RNA
was extracted by using the TRIzol Max bacterial RNA isolation kit (Thermo Fisher Scientiﬁc, Waltham, MA)
as speciﬁed by the manufacturer. The RNA samples were treated with DNase to remove contaminating
DNA traces by a DNA-free kit (Thermo Fisher Scientiﬁc). Finally, RNA samples without traces of DNA were
cleaned with the RNeasy PowerClean Pro cleanup kit (Qiagen, Hilden, Germany) and measured with a
NanoDrop 2000 spectrophotometer (Thermo Scientiﬁc, Littau, Switzerland).
RT-qPCR. A total of 200 ng of each RNA sample was reverse transcribed using the PrimeScript RT
reagent kit (TaKaRa, Saint-Germain-en-Laye, France) according to the manufacturer’s instructions. Quan-
titative real-time PCR (RT-qPCR) was performed using a RotorGene Q (Qiagen, Hilden, Germany).
Sequences of primers used are listed in Table 1. Reactions were set up in a total volume of 25 l with a
Rotor-Gene SYBR green PCR kit (Qiagen, Hilden, Germany). The selected genes in this assay were 16S
rRNA (E. coli and B. gaviniae reference gene), mcr-1, and mcr-9, together with a fragment corresponding
to the iteron of the IncHI2 plasmid. Three independent replicates were performed with and without
induction. The obtained threshold cycle (CT) values were analyzed by the 2ΔΔCT method (43). Relative
expression levels were calculated and compared with those of samples that were not induced. All values
were corrected with values for the appropriate reference gene.
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Erratum for Kieffer et al., “mcr-9, an Inducible Gene Encoding
an Acquired Phosphoethanolamine Transferase in Escherichia
coli, and Its Origin”
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Volume 63, no. 9, e00965-19, 2019, https://doi.org/10.1128/AAC.00965-19. Discus-
sion section, 5th paragraph: The primer sequences were incorrect in the originally
published article and should read as follows. MCR-9F (5’-GGT GAA AGT TAT TCC GCT
GG-3’) and MCR-9R (5’-TCG CGG TCA GGA TTA TAG AC-3’).
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